(Q41705967)

English

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours

scientific article published on January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 October 2017

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours (English)

1 reference

Europe PubMed Central

7 October 2017

1

1 reference

Europe PubMed Central

7 October 2017

author name string

C Bassi

2

1 reference

Europe PubMed Central

7 October 2017

C Salvi

3

1 reference

Europe PubMed Central

7 October 2017

G Parmiani

4

1 reference

Europe PubMed Central

7 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

7 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

7 October 2017

34

1 reference

Europe PubMed Central

7 October 2017

1

1 reference

Europe PubMed Central

7 October 2017

53-62

1 reference

Europe PubMed Central

7 October 2017

https://scigraph.springernature.com/pub.10.1007/bf01741325

0 references

Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of chemically induced murine colon cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experime

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of disseminated tumors by adoptive transfer of specifically immune T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of murine colonic adenocarcinoma by tumor immune but not by IL-2-activated or alloactivated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effector phenotype and immunologic specificity of T-cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs

1 reference

https://pubmed.ncbi.nlm.nih.gov/1760812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01741325

1 reference

Europe PubMed Central

7 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41705967&oldid=2100292445"